Summary
The Trump administration has delayed and might cancel about $140 million in grants meant for fighting fentanyl overdoses in the U.S. This funding is crucial for many state and local public health programs that work to reduce drug overdose deaths.
Key Facts
- The possible funding cut affects nearly half of the money Congress set aside for the Overdose To Action (OD2A) program.
- The delay impacts programs in 49 states, Washington D.C., and numerous city, county, and territorial health departments.
- CDC staff shared information anonymously, fearing backlash for speaking out.
- The money is used to help reduce deaths caused by fentanyl and other dangerous drugs.
- Previous disruptions in addiction care, like during COVID-19, led to an increase in drug deaths.
- The delay is reportedly due to administrative confusion linked to efforts to cut costs by the Department of Government Efficiency and the Office of Management and Budget.
- Health officials warn that if the funds are withheld, it could lead to layoffs and program shutdowns in public health departments.
